SARS-CoV-2 vs. SARS-CoV-1 management: antibiotics and inflammasome modulators potential

Rat, P; Olivier, E; Dutot, M

Dutot, M (corresponding author), Univ Paris, Fac Pharm, Chim Toxicol Analyt & Cellulaire, UMR CNRS 8038 CiTCoM, Paris, France.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020; 24 (14): 7880

Abstract

The coronavirus SARS-CoV-2 at the origin of COVID-19 shares more than 70% genetic similarity with SARS-CoV-1 that was at the origin of 2003 SARS. Infe......

Full Text Link